Disease/Infection News

RSS

The technology behind face masks that can diagnose COVID-19

Researchers have recently incorporated technology into standard face masks to detect the presence of SARS-CoV-2.

29 Jun 2021

How does dexamethasone therapy work in severe COVID-19?

The possible mechanisms that result in dexamethasone being an effective drug against severe SARS-CoV-2 infection are investigated in a new study. The paper’s authors advance the hypothesis that SARS-CoV-2 infection induces cell-specific insensitivity to glucocorticoids, possibly as an unintentional result of the viral replication cycle.

29 Jun 2021

Cationic peptides inhibit SARS-CoV-2 cell entry

In a paper recently published in Pathogens, in silico affinity studies by researchers at the University of Illinois, USA, reveal several potential peptide binding sites required for HS-spike protein and ACE2-spike protein bond formation, and synthesis of suitable peptide inhibitors reveals impaired SARS-CoV-2 cell entry.

29 Jun 2021

Nanotechnology and the fight against COVID-19

In a review paper published in the open-access MDPI journal Viruses, a team of researchers explored the potential of nanotechnology to alleviate the current and future coronavirus burden. The team focused on its potential role in the detection, diagnosis, protection, and treatment of SARS-CoV-2 infection.

29 Jun 2021

Analysis: Why we’ll likely never know whether a covid lab leak happened in China

Early in this century, post-SARS, and in a period when China started allowing more students and scientists to study abroad, collaboration and exchange between American and Chinese scientists blossomed.

29 Jun 2021

Findings suggest that the cross-linking of fibrin proteins is key to reducing blood clot formation

Researchers have found that the y cross-chain structure of fibrin proteins is essential to stabilizing blood clots that can lead to harmful embolism formation.

29 Jun 2021

Clinical observations show acute myocarditis developed after mRNA COVID-19 vaccination

Four patients suffering from acute myocarditis after mRNA COVID-19 vaccination suggests that further investigation is needed.

29 Jun 2021

Study explores structure, activity, and inhibition of TMPRSS2 implicated in SARS-CoV-2 activation

Researchers from Canada recently presented an efficient strategy for recombinant production of enzymatically active TMPRSS2 ectodomain, enabling enzymatic characterization and the 1.95 Å X-ray crystal structure. Their work is published on the bioRxiv* preprint server while awaiting peer-review.

29 Jun 2021

New spider web mechanism kills pathogens and virus responsible for COVID-19

Immunologists at McMaster University have discovered a previously unknown mechanism which acts like a spider web, trapping and killing pathogens such as influenza or SARS-CoV-2, the virus responsible for COVID-19.

29 Jun 2021

Tackling emerging SARS-CoV-2 variants

An international team of authors has published a special report in The New England Journal of Medicine titled 'SARS-CoV-2 Variants and Vaccines’, which presents global strategies for the possible escape from vaccine-elicited immunity.

29 Jun 2021

Many survivors of adolescent and young adult cancers hesitate to get COVID-19 vaccinations

A new paper in JNCI Cancer Spectrum, published by Oxford University Press, indicates that many survivors of adolescent and young adult cancers hesitate to obtain COVID-19 vaccinations.

29 Jun 2021

Public opinion surveys could be used to understand regional variation in vaccine hesitancy, say experts

Public opinion surveys could be used more widely to understand regional variation in vaccine hesitancy, experts have recommended.

29 Jun 2021

SARS-CoV-2 infection induces accumulation of lipids and N-proteins

Scientists from the Netherlands and the US recently studied the localization of the SARS-CoV-2 proteins in postmortem lung tissues of COVID-19 patients and in SARS-CoV-2 infected Vero cells that were processed identically. The research is posted to the bioRxiv* preprint server, prior to peer review.

29 Jun 2021

Rapid test kit for malaria delivers results in 30 minutes

A team of scientists from Nanyang Technological University, Singapore (NTU Singapore) has developed a test kit for malaria that delivers results in 30 minutes. The kit could facilitate the diagnosis of malaria in the field, as the equipment needed is anticipated to be lightweight, easy-to-use, and able to detect the disease in its early stages.

29 Jun 2021

Cyber security experts may hold the key to rollout of vaccine passports

Leading cybersecurity industry expert, Koji Fusa, has made progress towards developing a framework for the world's citizens to store their digital identities and access them in real-time. Koji is a Visiting Professor at the Cyber Security Innovation Research Centre (CSI) at Aston University.

29 Jun 2021

Aerosol generated by playing wind instruments is less than that produced when vocalizing

Aerosol generated by playing woodwind and brass instruments is less than that produced when vocalizing (speaking and singing) and is no different than a person breathing, new research has found.

29 Jun 2021

SARS-CoV-2 test in 20 minutes with FISH

A collaboration from the University of Oxford and the University of Warwick has led to research into a novel method of viral detection through rapid fluorescence in situ hybridization (FISH) in order to effectively detect the SARS-CoV-2 virus within 20 minutes.

29 Jun 2021

Immune response to FDA-approved vaccines is strong and potentially long-lasting

The first two COVID-19 vaccines authorized for emergency use by the Food and Drug Administration (FDA) employed a technology that had never before been used in FDA-approved vaccines.

29 Jun 2021

Study finds evidence for adverse effects of COVID-19 pandemic on cancer detection, surgical treatments

A new study finds evidence for adverse effects of the COVID-19 pandemic on declines in cancer detection and surgical treatments.

29 Jun 2021

What's behind COVID-19 vaccine side effects?

A growing concern among coronavirus vaccines is the vaccine side effects. Fear or misinformation about side effects may fuel vaccine hesitancy, contributing to low vaccination rates. Australian researchers recently published an article in Science Immunology to discuss why people develop side effects and their benefits.

28 Jun 2021

Disease/Infection News

The technology behind face masks that can diagnose COVID-19

How does dexamethasone therapy work in severe COVID-19?

Cationic peptides inhibit SARS-CoV-2 cell entry

Nanotechnology and the fight against COVID-19

Analysis: Why we’ll likely never know whether a covid lab leak happened in China

Findings suggest that the cross-linking of fibrin proteins is key to reducing blood clot formation

Clinical observations show acute myocarditis developed after mRNA COVID-19 vaccination

Study explores structure, activity, and inhibition of TMPRSS2 implicated in SARS-CoV-2 activation

New spider web mechanism kills pathogens and virus responsible for COVID-19

Tackling emerging SARS-CoV-2 variants

Many survivors of adolescent and young adult cancers hesitate to get COVID-19 vaccinations

Public opinion surveys could be used to understand regional variation in vaccine hesitancy, say experts

SARS-CoV-2 infection induces accumulation of lipids and N-proteins

Rapid test kit for malaria delivers results in 30 minutes

Cyber security experts may hold the key to rollout of vaccine passports

Aerosol generated by playing wind instruments is less than that produced when vocalizing

SARS-CoV-2 test in 20 minutes with FISH

Immune response to FDA-approved vaccines is strong and potentially long-lasting

Study finds evidence for adverse effects of COVID-19 pandemic on cancer detection, surgical treatments

What's behind COVID-19 vaccine side effects?

Decoding Cannabis: Differentiating Hemp and Marijuana

Deciphering the Microbiome with The Microsetta Initiative

Leveraging the power of automation to boost research

Latest News